The use of beta agonists and the risk of death and near death from asthma

Journal of Clinical Epidemiology

Volumn 62, Issue 6, 2009, Pages 582-587

  Pearce, Neil ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FENOTEROL; SALBUTAMOL; STEROID;

ARTICLE; ASTHMA; DRUG DOSE COMPARISON; DRUG FATALITY; HUMAN; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ASTHMA; BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DATA INTERPRETATION, STATISTICAL; DRUG TOXICITY; FENOTEROL; HISTORY, 20TH CENTURY; HUMANS; MIDDLE AGED; NEW ZEALAND; RESEARCH DESIGN; RISK; YOUNG ADULT;

EID: 65349113777     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2009.01.004     Document Type: Article

References (26)

1. Crane J., Pearce N., Flatt A., Burgess C., Jackson R., Kwong T., et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet 1 (1989) 917-922 [comment]
2. Pearce N., Grainger J., Atkinson M., Crane J., Burgess C., Culling C., et al. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax 45 (1990) 170-175 [comment]
3. Grainger J., Woodman K., Pearce N., Crane J., Burgess C., Keane A., et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax 46 (1991) 105-111 [comment]
4. Pearce N., Crane J., Burgess C., Jackson R., and Beasley R. Beta agonists and asthma mortality: deja vu. Clin Exp Allergy 21 (1991) 401-410
5. Stolley P.D. Why the United States was spared an epidemic of deaths due to asthma. Am Rev Respir Dis 105 (1972) 883-890
6. Pearce N. Adverse reactions, social responses: a tale of two asthma mortality epidemics. In: Davis P. (Ed). Contested ground: public purpose and private interest in the regulation of prescription drugs (1996), Oxford University Press, New York 57-75
7. Pearce N. Adverse reactions: the fenoterol story (2007), Auckland University Press, Auckland
8. Buist A.S., Burney P.G.J., Feinstein A.R., Horwitz R.I., Lanes S.F., Rebuck A.S., et al. Fenoterol and fatal asthma. Lancet 334 (1989) 1071
9. Sackett D.L., Shannon H.S., and Browman G.W. Fenoterol and fatal asthma. Lancet 335 (1990) 45-46
10. Spitzer W.O., Suissa S., Ernst P., Horwitz R.I., Habbick B., Cockcroft D., et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 326 (1992) 501-506
11. Pearce N., Beasley R., Crane J., Burgess C., and Jackson R. End of the New Zealand asthma mortality epidemic. Lancet 345 (1995) 41-44 [comment]
12. Suissa S., Ernst P., Boivin J.F., Horwitz R.I., Habbick B., Cockroft D., et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 149 (1994) 604-610
13. Pearce N., and Hensley M.J. Epidemiologic studies of beta agonists and asthma deaths. Epidemiol Rev 20 (1998) 173-186
14. Burgess C., Pearce N., Thiruchelvam R., Wilkinson R., Linaker C., Woodman K., et al. Prescribed drug therapy and near-fatal asthma attacks. Eur Respir J 7 (1994) 498-503
15. Hensley M.J. Fenoterol and death from asthma. Med J Aust 156 (1992) 882
16. Horwitz R.I., Spitzer W., Buist S., Cockcroft D., Ernst P., Habbick B., et al. Clinical complexity and epidemiologic uncertainty in case-control research: fenoterol and asthma management. Chest 100 (1991) 1586-1591
17. Bown W. Warning letter links asthma deaths to drugs. New Scientist (27 July 1991) p 9
18. Spitzer W.O., Suissa S., Ernst P., Horwitz R.I., Habbick B., Cockcroft D., et al. Saskatchewan asthma epidemiology study: results of the nested case-control phase assessing the association between beta-agonists and asthma death and near-death (1991), McGill University, Montreal
19. Beasley R., Pearce N., Crane J., Windom H., and Burgess C. Asthma mortality and inhaled beta agonist therapy. Aust N Z J Med 21 (1991) 753-763 [comment]
20. Mullen M., Mullen B., and Carey M. The association between beta-agonist use and death from asthma-a metaanalytic integration of case-control studies. JAMA 270 (1993) 1842-1845
21. Miller D.B., and Strunk R.C. Circumstances surrounding the deaths of children due to asthma: a case-control study. Am J Dis Chest 143 (1989) 1294-1299
22. Strunk R.C., Mrazek D.A., Fuhrmann G.S., and LaBrecque J.F. Physiologic and psychologic characteristics associated with deaths due to asthma in childhood. JAMA 254 (1985) 1193-1198
23. Woodman K., Pearce N., Beasley R., Burgess C., and Crane J. Albuterol and deaths from asthma in New Zealand from 1969 to 1976: a case-control study. Clin Pharmacol Ther 51 (1992) 566-571
24. Beasley R., Burgess C., Pearce N., Woodman K., and Crane J. Confounding by severity does not explain the association between fenoterol and asthma death. Clin Exp Allergy 24 (1994) 660-668
25. Pearce N. Corporate influences on epidemiology. Int J Epidemiol 47 (2008) 46-53
26. Anonymous. Asthma drug controversy climaxes with government decision to restrict use. Epidemiol Monit 11 3 (1990) 1-5